XML 18 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities:    
Net income (loss) $ 28,548 $ (81,949)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 10,834 8,912
Stock-based compensation expense 4,869 7,993
Inventory impairments and abandonments 2,266 148,618
Deferred and other income tax expense (benefit) 8,900 (44,758)
Gain on sale of fixed assets (195) (142)
Change in allowance for doubtful accounts (6) (20)
Equity in income of unconsolidated entities (138) (315)
Cash distributions of income from unconsolidated entities 56 409
Loss (gain) on extinguishment of debt, net 0 (574)
Changes in operating assets and liabilities:    
Decrease in accounts receivable 8,555 4,380
Decrease in income tax receivable 315 0
Increase in inventory (6,616) (156,472)
Increase in other assets (1,377) (776)
Increase in trade accounts payable 48 26,009
Increase (decrease) in other liabilities 2,897 (5,520)
Net cash provided by (used in) operating activities 58,956 (94,205)
Cash flows from investing activities:    
Capital expenditures (7,510) (16,365)
Proceeds from sale of fixed assets 214 162
Acquisition, net of cash acquired 0 (4,088)
Net cash used in investing activities (7,296) (20,291)
Cash flows from financing activities:    
Repayment of debt (1,150) (22,333)
Repayment of borrowings from credit facility (345,000) (235,000)
Borrowings from credit facility 345,000 340,000
Debt issuance costs (97) (400)
Repurchase of common stock (3,327) (34,624)
Tax payments for stock-based compensation awards (2,674) (1,889)
Stock option exercises and other financing activities (1,854) 278
Net cash (used in) provided by financing activities (9,102) 46,032
Net increase (decrease) in cash, cash equivalents, and restricted cash 42,558 (68,464)
Cash, cash equivalents, and restricted cash at beginning of period 122,794 153,248
Cash, cash equivalents, and restricted cash at end of period $ 165,352 $ 84,784